Minoxidil

Uses and routes

Minoxidil is a small-molecule medicine that can increase hair growth in people with pattern hair loss. Topical products are applied to the scalp. Oral tablets enter the circulation and were originally developed for severe high blood pressure.^511,512,513

Form	Where it stands
Topical solution or foam	Approved products treat pattern hair loss. The label depends on the product, country and intended user.
Standard oral tablets	Approved for severe hypertension. Clinicians also prescribe them off-label for hair loss.
Extended-release oral minoxidil	VDPHL01 is being studied for pattern hair loss, with company-reported results in 2026.

The mechanism

Minoxidil changes the hair-growth cycle and can increase hair thickness. Sulfotransferase enzymes convert it to an active sulfate metabolite. Several biological pathways may contribute to hair growth; the full mechanism is unresolved.^515,516

How much regrowth?

Trials count hairs in a defined area of scalp and assess visible change.

45% more

Relative hair regrowth with 5% solution compared with 2% solution in a randomized trial. Both strengths were also compared with placebo. Itching and local irritation were more common with 5%.⁵¹⁷

Foam in men

A separate trial enrolled 352 men and compared 5% foam with vehicle foam for 16 weeks. The average increase in non-vellus hair count was 21.0 versus 4.3 hairs per square centimeter. These results come from a different formulation and study period.⁵¹⁸

Foam in women

In a 24-week trial, women using 5% foam once daily gained an average of 13.4 non-vellus hairs per square centimeter, compared with 4.3 using vehicle foam.⁵¹⁶

Once-daily foam versus twice-daily solution

A trial of 322 women found very similar hair-count gains with 5% foam once daily and 2% solution twice daily: 23.9 and 24.2 hairs per square centimeter at 24 weeks. The trial missed its predefined test for comparable effectiveness.⁵¹⁹

Keeping the result

The product labels require continued use to maintain regrowth. An early study followed ten men after they stopped topical treatment and found that most of the recruited hairs were lost.^511,512,520

A Chinese study from 2026

Researchers assigned 120 men to topical 5% minoxidil alone or the same treatment with roller microneedling. The journal abstract reports larger gains in coarse-hair count and density with the added procedure. It describes 60 men per group but gives no treatment duration or blinding details.⁵²¹

Women's microneedling trial

A separate trial randomized 245 women to topical 2% minoxidil alone or with microneedling. Among 234 who completed 24 weeks, the added procedure gave no extra clinical benefit. The trial was open-label and used a different population and strength from the Chinese study.⁵²²

A Russian clinical report

A Russian study followed 21 adults using 5% foam for three months. The authors reported a 16.4% average increase in terminal-hair count. All participants completed treatment; there was no comparison group.⁵²³

Is the pill better?

The cited comparison trials found no hair-density advantage for standard oral minoxidil.

A direct comparison

A Brazilian trial randomized 90 men to oral minoxidil 5 mg daily or topical minoxidil 5% twice daily for 24 weeks. Sixty-eight completed the study. Oral treatment did not show superiority on the primary frontal or vertex hair-density measurements. A secondary photographic assessment favored oral treatment at the vertex.⁵²⁴

Across four trials

A meta-analysis pooled four randomized trials with 279 participants. Hair density and diameter did not differ significantly between oral and topical treatment. Unwanted hair growth was more frequent with oral minoxidil.⁵²⁵

Side effects in hair-loss treatment

In the Brazilian trial, 22 of 45 men assigned oral minoxidil reported unwanted hair growth and six reported headache. A separate retrospective study followed 1,404 people using low-dose oral minoxidil and recorded unwanted hair growth, lightheadedness, fluid retention and a faster heartbeat.^524,526

An extended-release formulation

In April 2026, Veradermics reported results from a 519-man trial of VDPHL01. At six months, average non-vellus hair-count gains were 30.3 and 33.0 hairs per square centimeter in the two active groups, versus 7.3 with placebo. These are company-reported results for an investigational formulation. The program includes separate trials in women.^514,527

Safety by formulation

Scalp products carry local and systemic warnings; tablets add systemic exposure.

Scalp irritation and shedding

Topical products can cause itching, redness and irritation. The UK foam labels describe temporary shedding two to six weeks after starting. Persistent shedding, an inflamed scalp or sudden patchy hair loss needs assessment.^518,516

Heart and fluid symptoms

Chest pain, a rapid heartbeat, faintness, sudden unexplained weight gain or swollen hands and feet are reasons to stop a topical product and seek medical advice. Oral minoxidil carries warnings for fluid retention and fluid around the heart. Its hypertension-label event rates come from a different population than low-dose hair-loss studies.^511,512,513

Pregnancy and breastfeeding

Topical labels advise against use during pregnancy and breastfeeding. Oral-label evidence includes reports of newborn hair growth after exposure during pregnancy and minoxidil passing into breast milk.^516,513

Contact with babies

European regulators added warnings after infants developed excessive hair growth following skin contact with a caregiver's treated areas. Wash hands after application and prevent children from touching application sites.^528,516

Pets

Minoxidil can poison cats and dogs, including after licking treated skin or a pillowcase. A poison-center study identified 211 exposures; among 62 cats that developed symptoms, eight died. Keep pets away from the medicine, treated skin and contaminated items. Suspected exposure needs urgent veterinary advice.^529,530

Product quality

FDA testing in a compounding investigation found an average of 127.86 mg of undeclared minoxidil in capsules labeled as a finasteride product. This was a manufacturing failure involving a specific product. The same records include recalls for excessive strength, labeling errors and deficient processing controls.^531,532

Common questions

Results, practical choices and side effects.

01 Is oral minoxidil better than topical minoxidil?

No clear advantage has been shown. In a 90-man trial with 68 completers, oral 5 mg did not show superiority over topical 5% on the primary frontal or vertex density comparisons; a four-trial meta-analysis of 279 participants likewise found no density or diameter advantage. Oral hair use is off-label and produced more unwanted hair growth in the meta-analysis.^524,525,513

02 How long does minoxidil take to work?

The current US men's foam label says results may take four months, while the women's foam label says six months. A current UK men's foam trial measured a 16-week increase of 21.0 nonvellus hairs/cm² with active foam versus 4.3 with vehicle.^511,512,518

03 What side effects should I watch for?

Topical products can cause scalp irritation and unwanted hair, and their labels flag chest pain, rapid heartbeat, dizziness, sudden weight gain or swelling for medical review. Oral exposure adds systemic risks such as fluid retention, tachycardia, worsening angina and pericardial effusion. In a retrospective 1,404-person hair-loss cohort, unwanted hair growth was most common; the study had no control group.^{511,512,513,526}

04 Can I combine minoxidil with finasteride or other hair medicines?

The evidence applies to the exact drugs, routes and populations tested. In 450 randomized Chinese men, 428 were evaluated at 12 months and categorical improvement was reported in 80.5% with oral finasteride, 59.0% with topical minoxidil and 94.1% with the combination.⁵³³

05 Should I use foam or liquid, and how often?

It depends on the product. Current US labels specify once-daily use for the selected women's 5% foam and twice-daily use for the men's foam. A 322-woman trial found similar hair-count gains with once-daily 5% foam and twice-daily 2% solution, but missed its predefined test for comparable effectiveness.^511,512,519

06 Is early shedding normal?

It can occur: the current UK men's foam label describes increased shedding during the first two to six weeks as the hair cycle changes. Shedding is not proof that treatment will work, and sudden, patchy or unexplained loss falls outside ordinary pattern-hair-loss labeling.^518,511,512

07 Does minoxidil work for women?

Yes, for female pattern hair loss in the studied scalp area. In a 381-woman, 48-week trial, 5% solution beat vehicle on all three primary measures, with more itching, irritation and unwanted hair growth than 2% or vehicle. The current US women's 5% foam label covers hereditary thinning on the top of the scalp.^534,512

08 Does minoxidil work on a receding hairline or beard?

Current US OTC labels cover hereditary thinning on the top or vertex scalp. Beard use falls outside those labels. A 24-week male scalp trial measured frontal and vertex density, while a separate 12-week placebo-controlled trial in 69 transgender men found greater beard and mustache density with topical 3% minoxidil. The facial study was short and used an off-label site.^{511,512,524,535}

09 What happens if I stop minoxidil?

The added growth is usually not maintained. In a direct 10-man withdrawal study, most recruited hairs were lost after topical minoxidil stopped and four men fell below their baseline target-area count.^520,511,512

10 How much does minoxidil cost, and is it over the counter?

The current US topical Rogaine foam products are sold over the counter. Oral minoxidil tablets require a prescription for severe refractory hypertension, and hair-loss use is off-label. Product labels do not list current retail prices or insurance criteria.^{511,512,513,536}

11 Can minoxidil affect my heart or blood pressure?

Yes. Oral minoxidil is a vasodilator reserved by its US label for severe refractory hypertension and can cause fluid retention, faster heart rate, worsening angina and pericardial effusion. Topical labels still flag chest pain, rapid heartbeat, dizziness, swelling and sudden weight gain.^513,511,512

12 Is minoxidil dangerous to cats or dogs?

Yes. A poison-center series found 87 symptomatic cases among 211 dog and cat exposures; 8 of 62 symptomatic cats died, and signs occurred after small exposures such as drops or licks. The AAD advises preventing contact with treated skin, bedding, spills, packaging and tablets and seeking urgent veterinary care after exposure.^529,530

13 Can minoxidil cause dandruff or scalp irritation?

Scalp irritation and itching are recognized topical effects. A review of 99 patch-test-confirmed contact-allergy cases found minoxidil itself was the identified allergen in 74.7% and propylene glycol in 17.1%. The confirmed allergens included both the active drug and the vehicle.^511,512,537

14 Is minoxidil safe in pregnancy or breastfeeding?

The current US women's foam label says not to use it during pregnancy or breastfeeding. The current oral label says adequate controlled pregnancy studies are lacking, neonatal hypertrichosis has been reported, and nursing use is not recommended. European labeling also warns that infant contact with a caregiver's treated skin can cause excessive hair growth.^512,513,528

15 Can minoxidil cause unwanted facial or body hair?

Yes. Unwanted facial hair appears in topical labeling, and unwanted hair growth occurred in 22 of 45 people assigned oral treatment in the 24-week oral-versus-topical trial. Oral exposure produced more unwanted hair growth than topical treatment in the four-trial meta-analysis.^512,524,525